MISSED OPPORTUNITIES IN THE MONITORING OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS)

被引：0
|
作者：
Dyaanand, H. [1 ]
Dickson, M. [1 ]
Tilley, D. [1 ]
Nisar, M. [1 ]
机构：
[1] Queens Hosp, Dept Rheumatol, Burton Upon Trent, England
来源：
RHEUMATOLOGY | 2002年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [41] CONTRACEPTIVE USE IN WOMEN WITH RHEUMATOLOGIC DISEASE TAKING DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    O'Neill, C.
    Ngian, G.
    Nicholson, P.
    Van Doornum, S.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 44 - 44
  • [42] Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
    Atzeni, Fabiola
    Gerratana, Elisabetta
    Francesco Masala, Ignazio
    Bongiovanni, Sara
    Sarzi-Puttini, Piercarlo
    Rodriguez-Carrio, Javier
    FRONTIERS IN MEDICINE, 2021, 8
  • [43] Parasitic helminths and protozoa: Treasure boxes of disease modifying anti-rheumatic drugs
    Osada, Yoshio
    Shimizu, Shoichi
    Morita, Kentaro
    PARASITOLOGY INTERNATIONAL, 2025, 105
  • [44] TUBERCULOSIS RISK IN CHILDREN WITH RHEUMATIC DISEASES TREATED WITH BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Kavadichanda, C.
    Ajmani, S.
    Maccora, I.
    Balan, S.
    Ramanan, A.
    Agarwal, V.
    Gupta, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1784 - 1785
  • [45] Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis
    Haibel, H.
    Specker, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S159 - S163
  • [46] The use of conventional disease-modifying anti-rheumatic drugs in established RA
    Jurgens, M. S.
    Jacobs, J. W. G.
    Bijlsma, J. W. J.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2011, 25 (04): : 523 - 533
  • [47] PATIENTS' BELIEFS RELATING TO THE USE AND EFFICACY OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Goodacre, L. J.
    Smith, J.
    Goodacre, J. A.
    RHEUMATOLOGY, 2002, 41 : 73 - 73
  • [48] Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice
    Grove, ML
    Hassell, AB
    Hay, EM
    Shadforth, MF
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 2001, 94 (06): : 309 - 319
  • [49] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Monchablon, Clelia
    Gonde, Henri
    Pouplin, Sophie
    Varin, Remi
    Vittecoq, Olivier
    Lequerre, Thierry
    CLINICAL RHEUMATOLOGY, 2020, 39 (01) : 207 - 216
  • [50] Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Choy, Ernest
    Aletaha, Daniel
    Behrens, Frank
    Finckh, Axel
    Gomez-Reino, Juan
    Gottenberg, Jacques-Eric
    Schuch, Florian
    Rubbert-Roth, Andrea
    RHEUMATOLOGY, 2017, 56 (05) : 689 - 697
12345